• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类甲状腺功能减退症中凝血酶原复合物凝血因子的代谢

Metabolism of the coagulation factors of the prothrombin complex in hypothyroidism in man.

作者信息

van Oosterom A T, Kerkhoven P, Veltkamp J J

出版信息

Thromb Haemost. 1979 Apr 23;41(2):273-85.

PMID:473111
Abstract

The metabolic rate of prothrombin, factors VII, IX and X, was studied in nine hypothyroid patients. Disappearance rates of the four vitamin-K-dependent factors, called the prothrombin complex, were measured after assumedly complete blocking of their synthesis with adequate doses of a coumarin congener (acenocoumarol). Reappearance rates were assessed by induction of synthesis with high doses of vitamin K1 (phytomenadion) when stable hypocoagulability had been achieved. Normal values for these rates were derived from earlier studies in our laboratory. In hypothyroid patients the rates of both disappearance and reappearance were significantly slower for all factors tested. Practical consequences of these observations are discussed. The initial level of factor-IX activity in all nine patients was substantially lower than in normal individuals. Therapy by thyroxine-substitution led to normal levels of factor-IX. This implies a divergency in the retardation of the breakdown and production rates in hypothyroidism. The reappearance rate was indeed found to be more retarded than the disappearance rate.

摘要

对9例甲状腺功能减退患者的凝血酶原、因子VII、IX和X的代谢率进行了研究。在用足量香豆素同类物(醋硝香豆素)假定完全阻断其合成后,测定了这四种维生素K依赖因子(称为凝血酶原复合物)的消失率。当达到稳定的低凝状态时,通过高剂量维生素K1(植物甲萘醌)诱导合成来评估再出现率。这些速率的正常值来自我们实验室早期的研究。在甲状腺功能减退患者中,所有测试因子的消失率和再出现率均明显较慢。讨论了这些观察结果的实际意义。所有9例患者的因子IX活性初始水平均显著低于正常个体。甲状腺素替代治疗使因子IX水平恢复正常。这意味着甲状腺功能减退时分解速率和产生速率的延缓存在差异。实际上发现再出现率比消失率更迟缓。

相似文献

1
Metabolism of the coagulation factors of the prothrombin complex in hypothyroidism in man.人类甲状腺功能减退症中凝血酶原复合物凝血因子的代谢
Thromb Haemost. 1979 Apr 23;41(2):273-85.
2
The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat.甲状腺功能对大鼠凝血酶原、凝血因子VII和凝血因子X代谢率的影响。
Thromb Haemost. 1976 Jun 30;35(3):607-19.
3
Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats.华法林对大鼠维生素K依赖凝血因子动力学的影响。
J Pharmacol Exp Ther. 1977 May;201(2):507-17.
4
Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease.在有缺血性心脏病近亲的年轻成年人中,维生素K依赖凝血因子水平升高。
J Lab Clin Med. 1993 Dec;122(6):720-7.
5
[Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].[口服和肌内注射维生素K对60日龄以内新生儿的凝血因子II、VII、IX、X及异常凝血酶原II的影响]
Rev Med Chil. 2001 Oct;129(10):1121-9.
6
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.
7
Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.紧急口服抗凝剂逆转:输注新鲜冰冻血浆和凝血因子浓缩物对纠正凝血病的相对疗效。
Thromb Haemost. 1997 Mar;77(3):477-80.
8
Warfarin therapy. 1.华法林治疗。1.
N Engl J Med. 1970 Sep 24;283(13):691-4. doi: 10.1056/NEJM197009242831307.
9
Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.凝血酶生成与凝血因子活性:与国际标准化比值的评估及比较
Blood Coagul Fibrinolysis. 2009 Jul;20(5):358-65. doi: 10.1097/MBC.0b013e32832aa68c.
10
Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.口服抗凝治疗早期和稳定期国际标准化比值、维生素K依赖凝血因子水平与体内凝血酶原激活之间的关系
Haematologica. 2002 Oct;87(10):1074-80.

引用本文的文献

1
Procoagulant and anticoagulant factors in childhood hypothyroidism.儿童甲状腺功能减退症中的促凝和抗凝因子。
Int J Endocrinol. 2012;2012:156854. doi: 10.1155/2012/156854. Epub 2012 Jul 3.
2
Hemostasis and thyroid diseases revisited.再谈止血与甲状腺疾病。
J Endocrinol Invest. 2004 Oct;27(9):886-92. doi: 10.1007/BF03346287.
3
Coagulation inhibitor in hypothyroidism.甲状腺功能减退症中的凝血抑制剂。
Br Med J (Clin Res Ed). 1981 May 9;282(6275):1508. doi: 10.1136/bmj.282.6275.1508.